NL-OMON25184尚未招募不适用
Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma – a multicenter phase I/II safety study
Academic Medical Center (AMC)0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 18 years or older;
- •- Capable of providing written and oral informed consent;
排除标准
- •- Resectable PHC upon exploratory laparotomy;
- •- Locally advanced PHC eligible for liver transplantation;
研究者
相似试验
已完成
2 期
Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma - a multicenter phase I/II safety studyKlatskin tumorperihilar bile duct tumorPerihilar cholangiocarcinoma10019654NL-OMON50469Academisch Medisch Centrum12
进行中（未招募）
1 期
Irreversible electroporation (NanoKnife) in combination with immunotherapy for non-curable pancreatic cancerPatients with non-curable pancreatic cancerMedDRA version: 20.0Level: LLTClassification code 10033575Term: Pancreas cancerSystem Organ Class: 100000004864EUCTR2020-004623-17-DKZealand University Hospital12
已完成
3 期
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF (PULSED AF)JPRN-jRCT2052210035Shiomitsu Aki400
已完成
不适用
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF (PULSED AF)atrial fibrillationNL-OMON55237Medtronic BV50
招募中
不适用
A pilot study evaluating focal irreversible electroporation as treatment for participants with recurrent prostate cancer after radiotherapy.Recurrent Prostate CancerACTRN12617000806369St. Vincent’s Private Hospital10